Stockscreener 앱 받기
4.18
0.00%
0.00
전일 마감가:
$4.18
열려 있는:
$4.17
하루 거래량:
101.57K
Relative Volume:
0.50
시가총액:
$30.31M
수익:
-
순이익/손실:
$-29.96M
주가수익비율:
-0.1513
EPS:
-27.6253
순현금흐름:
$-31.64M
1주 성능:
+7.73%
1개월 성능:
+0.97%
6개월 성능:
-62.00%
1년 성능:
+1.95%
1일 변동 폭
$4.1063
$4.23
1주일 범위
$3.88
$4.23
52주 변동 폭
$0.61
$14.68
Briacell Therapeutics Corp Stock (BCTX) Company Profile
명칭
Briacell Therapeutics Corp
전화
(604) 921-1810
주소
3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR, WEST VANCOUVER
Compare BCTX vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BCTX
Briacell Therapeutics Corp
|
4.18 | 30.31M | 0 | -29.96M | -31.64M | -27.63 |
VRTX
Vertex Pharmaceuticals Inc
|
423.92 | 107.83B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
701.42 | 73.54B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
783.50 | 48.72B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
296.11 | 39.51B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
293.86 | 32.66B | 5.36B | 287.73M | 924.18M | 2.5229 |
Briacell Therapeutics Corp Stock (BCTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-02-14 | 개시 | H.C. Wainwright | Buy |
Briacell Therapeutics Corp 주식(BCTX)의 최신 뉴스
MSN Money - MSN
BriaCell Announces Six Clinical Data Presentations at ASCO 2026 - The Manila Times
Six metastatic breast cancer studies put BriaCell on ASCO's 2026 agenda - Stock Titan
BriaCell to implement 1-for-10 reverse stock split to maintain Nasdaq listing - MSN
BrianCell Therapeutics drops 10%, prices $30M offering at $5.59 per unit - MSN
BriaCell (BCTXL) Q4 Outlook Earnings ReportHigh Volatility - Xã Thanh Hà
BCTX (BriaCell Therapeutics Corp.) posts narrower than expected Q1 2026 loss, shares rise 1.76% today.Hot Community Stocks - Cổng thông tin điện tử Tỉnh Sơn La
BCTXZ (BriaCell) outlines late-stage oncology pipeline progress as key focus in latest quarterly earnings release.Crowd Consensus Signals - Cổng thông tin điện tử tỉnh Tây Ninh
BriaCell Shares Slide 22% After Announcing Dilutive Public Offering - MSN
BriaCell Therapeutics : Investor Presentation (2026Apr21 Investor Presentation) - marketscreener.com
Stocks in play: BriaCell Therapeutics Corp. - Barchart.com
BriaCell Therapeutics Corp. - Baystreet.ca
BriaCell (BCTX) Showcases Promising Data at AACR Annual Meeting - GuruFocus
BriaCell Presents Robust Anti-Cancer Activity of Bria-OTS+™ in Preclinical Cancer Models - The Manila Times
BriaCell presents phase 3 breast cancer quality of life data at AACR - Investing.com India
BriaCell Therapeutics : Investor Presentation (2026Apr20 Investor Presentation) - marketscreener.com
BriaCell (BCTX) Showcases Positive Clinical Data at AACR Annual Meeting - GuruFocus
BriaCell presents phase 3 breast cancer quality of life data at AACR By Investing.com - Investing.com South Africa
What should I do with BriaCell (BCTX) stock today (Pressure Mounts) 2026-04-20Retail Trader Ideas - Cổng thông tin điện tử tỉnh Lào Cai
BriaCell Presents Positive Phase 3 Quality of Life and Phase 2 Biomarker Data at the 2026 AACR Meeting - Investing News Network
Late-stage breast cancer patients preserved quality of life in trial - Stock Titan
BriaCell: Advancing Toward Approval with Late-Stage Breast Cancer Immunotherapy - The Globe and Mail
Certain Performance Share Units of BriaCell Therapeutics Corp. are subject to a Lock-Up Agreement Ending on 15-APR-2026. - marketscreener.com
Certain Options of BriaCell Therapeutics Corp. are subject to a Lock-Up Agreement Ending on 15-APR-2026. - marketscreener.com
Certain Warrants of BriaCell Therapeutics Corp. are subject to a Lock-Up Agreement Ending on 15-APR-2026. - marketscreener.com
BriaCell Therapeutics Corp. (BCTXW) - Minichart
BriaCell Stock Dips After-Hours On Pricing $13.8M Public Offering, But Retail's Busy Cheering Clinical Milestone - MSN
What is happening with BriaCell (BCTX) Stock right now | BCTX Q4 Earnings: Beats Estimates by $2.31Financial Update - UBND thành phố Hải Phòng
Growth Report: Does BriaCell Therapeutics Corp align with a passive investing strategy2026 Action & Growth Oriented Trade Recommendations - baoquankhu1.vn
Sectors Review: Is BriaCell Therapeutics Corp Equity Warrant stock a hidden gem2026 Key Lessons & Risk Managed Investment Signals - baoquankhu1.vn
Briacell Therap (NASDAQ:BCTX) Cut to “Strong Sell” at Wall Street Zen - Defense World
Is BriaCell (BCTXL) Stock Leading the Market | Price at $1.06, Up 2.40%Open Stock Signal Network - Xã Châu Thành
Quarterly Earnings: How does BriaCell Therapeutics Corp Equity Warrant compare to its peers2026 Volatility Report & Capital Protection Trading Alerts - baoquankhu1.vn
Is BriaCell (BCTX) Stock Worth Holding | Price at $4.47, Up 1.02%Stock Accumulation - Cổng thông tin điện tử tỉnh Lào Cai
Why Is BriaCell Therapeutics Corp. (BCTX) Stock Down Today? - Meyka
Will BriaCell (BCTXZ) Stock Grow in 2026 | Price at $0.14, Up 30.00%Top Analyst Picks - Cổng thông tin điện tử tỉnh Lào Cai
BCTX Pulls Back: Market Rotation Hits Healthcare - Cổng thông tin điện tử tỉnh Tây Ninh
BriaCell transfers cancer immunotherapy asset to BriaPro in USD$1.18 million deal - Mugglehead Investment Magazine
BCTX SEC FilingsBriacell Therapeutics Corp 10-K, 10-Q, 8-K Forms - Stock Titan
Sentiment Recap: What is BriaCell Therapeutics Corp Equity Warrants valuation compared to sectorRecession Risk & Advanced Swing Trade Entry Plans - baoquankhu1.vn
Technical Analysis: Does BriaCell Therapeutics Corp stock have upside surprise potentialQuarterly Portfolio Review & Risk Managed Investment Entry Signals - baoquankhu1.vn
BCTX Stock Analysis: BriaCell Therapeutics Corp Common Shares dips 1.19% to $4.14 - Cổng thông tin điện tử tỉnh Lào Cai
Published on: 2026-04-01 12:14:35 - baoquankhu1.vn
BriaCell Therapeutics Reports Rising Losses and Funding Pressure - TipRanks
BriaCell and BriaPro Announce Closing of Asset Purchase Transaction for Exclusive Soluble CD80 License - Investing News Network
Briacell Therapeutics Corp (BCTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.45%
자본화:
|
볼륨(24시간):